Affymax, Inc. (AFFY) Announces Update on Listing, Senior Leadership and Board Changes
6/7/2013 10:28:12 AM
More...
|
Affymax, Inc. (AFFY) CEO Steps Down as Restructuring Firm Steps in
5/15/2013 8:57:51 AM
More...
|
Affymax, Inc. (AFFY) Reports Fourth Quarter and Year-End 2012 Financial Results
4/2/2013 6:30:17 AM
More...
|
Affymax, Inc. (AFFY) May File for Bankruptcy; Cuts 75 Pct of Workforce
3/19/2013 7:18:09 AM
More...
|
Affymax, Inc. (AFFY) to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/7/2013 6:17:14 AM
More...
|
The New England Journal of Medicine Publishes Pivotal Trial Data for Affymax, Inc. (AFFY), and Takeda Pharmaceuticals's OMONTYS® (peginesatide) Injection for Treatment of Anemia in Adult Chronic Kidney Disease Patients on Hemodialysis
1/24/2013 9:01:03 AM
More...
|
Takeda Pharmaceutical Co. Ltd. (TKPYY) and Affymax, Inc. (AFFY) Announce Supply Agreement for OMONTYS® (Peginesatide) Injection With DSI Renal, Inc.
1/7/2013 10:07:12 AM
More...
|
Affymax, Inc. (AFFY) to Present at the J.P. Morgan Healthcare Conference
1/4/2013 6:13:20 AM
More...
|
Affymax, Inc. (AFFY) and Takeda Pharmaceuticals Announce Permanent J-Code for OMONTYS® (peginesatide) Injection is in Effect
1/3/2013 9:49:13 AM
More...
|
Affymax, Inc. (AFFY) to Present at the Lazard Capital Markets Healthcare Conference
11/12/2012 9:10:40 AM
More...
|
|